短病程与长病程1型糖尿病的β细胞量、功能、胰腺体积及脂肪差异:一项详细PET/CT成像研究
该汇总事后分析纳入16例短病程(<7年)和10例长病程(≥7年)1型糖尿病患者,采用[68Ga]Ga-NODAGA-exendin-4 PET/CT测定总β细胞量、混合餐耐量试验评估β细胞功能,并从CT获取胰腺体积和胰内脂肪沉积。结果显示短病程组总β细胞量更高(4.4 ± 1.8 vs. 2.8 ± 1.3 kBq/MBq,P = 0.012),胰腺体积更大、胰内脂肪沉积更低、β细胞功能更高;总β细胞量与β细胞功能(r = 0.46,P = 0.019)和胰腺体积(r = 0.91,P < 0.0001)正相关,与体重指数负相关(r = -0.61,P = 0.0009)。
要点
- 短病程1型糖尿病总β细胞量高于长病程组(4.4 ± 1.8 vs. 2.8 ± 1.3 kBq/MBq,P = 0.012)。
- 短病程组胰腺体积更大、胰内脂肪沉积更低、β细胞功能更高。
- 总β细胞量与β细胞功能、胰腺体积正相关,与体重指数负相关。
核心结论
- 短病程1型糖尿病个体总β细胞量高于长病程个体,且影像标志物联合功能试验有望监测疾病进展并为恢复β细胞功能或减缓β细胞破坏的时机提供信息。
研究设计与样本
- 汇总事后分析纳入16例短病程(<7年)和10例长病程(≥7年)1型糖尿病患者,采用[68Ga]Ga-NODAGA-exendin-4 PET/CT测定总β细胞量、混合餐耐量试验评估β细胞功能,并从CT获取胰内脂肪沉积和胰腺体积。
主要发现
- 短病程组总β细胞量高于长病程组(4.4 ± 1.8 vs. 2.8 ± 1.3 kBq/MBq,P = 0.012)。
- 短病程组较大胰腺体积、较低胰内脂肪沉积和较高β细胞功能均优于长病程组。
- 总β细胞量与β细胞功能正相关(r = 0.46,P = 0.019),与胰腺体积正相关(r = 0.91,P < 0.0001),与体重指数负相关(r = -0.61,P = 0.0009)。
临床怎么用
- 影像标志物联合功能试验可能用于监测1型糖尿病进展,并为恢复β细胞功能或减缓β细胞破坏的时机提供参考信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
People with recent-onset diabetes often have preserved C-peptide production, which tends to decline during the first 7 y after diagnosis and stabilizes thereafter. Whether this holds true for β-cell mass is unknown. In this pooled post hoc analysis, we aimed to investigate total β-cell mass in individuals with short- and long-duration type 1 diabetes. Methods: Data of 16 individuals with short- (<7 y) and 10 with long-duration type 1 diabetes (≥7 y) who underwent [68Ga]Ga-NODAGA-exendin-4 PET/CT and mixed-meal tolerance test were used to determine total β-cell mass and function, respectively. Intrapancreatic fat deposition and pancreatic volume were derived from CT. Results: Total β-cell mass was higher in individuals with short-duration type 1 diabetes compared with those with long-duration type 1 diabetes (4.4 ± 1.8 vs. 2.8 ± 1.3 kBq/MBq, P = 0.012). Larger pancreatic volume, lower intrapancreatic fat deposition, and higher β-cell function were observed in individuals with short-duration type 1 diabetes compared with the long-duration group. Total β-cell mass positively correlated with β-cell function (r = 0.46, P = 0.019) and pancreatic volume (r = 0.91, P < 0.0001) and inversely correlated with body mass index (r = -0.61, P = 0.0009). Conclusion: This study offers insights in the potential of imaging markers together with function tests to monitor disease progression and may offer valuable information for the timing to restore β-cell function or to slow down β-cell destruction.
引用
- Tokgöz S, de Groen P, Jansen TJP, et al. β-Cell Mass and Function, Pancreatic Volume, and Fat Differences Between Short- and Long-Duration Type 1 Diabetes: A Detailed PET/CT Imaging Study. J Nucl Med. 2026. PMID: 42850044. doi:10.2967/jnumed.126.272915
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。